Oncolytics Biotech Inc. (ONCY) Stock: Is This Biotechnology Stock Worth Your Investment?


Oncolytics Biotech Inc. (ONCY) is headed down in the market in today’s trading session. The company, one that is focused on the biotechnology industry, is presently priced at $0.90 after heading down -7.21% so far in today’s session. As it relates to biotech companies, there are quite a few factors that have the potential to generate movement in the market. News is one of the most common reasons for movement. Here are the most recent headlines associated with ONCY:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Aug-13-19 04:15PM Oncolytics Biotech(R) Announces Public Offering of Common Shares and Warrants
04:10PM Oncolytics Biotech(R) Reports 2019 Second Quarter Financial Results and Operational Highlights
Jul-23-19 07:00AM Oncolytics Biotech(R) Announces Preliminary AWARE-1 Trial Data Demonstrating Viral Replication and Promotion of Inflammation Following Systemic Administration of Pelareorep When Combined with Tecentriq(R)
Jun-05-19 07:00AM Oncolytics Biotech (R) to Host Conference Call to Discuss Co-Development Agreement with Pfizer and Merck KGaA
07:00AM Oncolytics Biotech (R) Announces Study to Investigate Combination of Pelareorep and Avelumab in Metastatic Breast Cancer in Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer

Nonetheless, any time investors are making a decision to invest, investors should focus on far more than just news, this is especially the case in the speculative biotechnology space. Here’s what’s happening in regard to Oncolytics Biotech Inc..

Returns That ONCY Investors Have Seen

Although a move down on a single session, like what we’re seeing from Oncolytics Biotech Inc. might cause fear in some investors, a single session move alone should not be the reason for a decision to, or not to, invest in a stock. It’s always smart to dig into trends just a single trading session. In the case of ONCY, here are the movements that we have seen:

  • Weekly – Over the past 5 trading sessions, ONCY has produced a change in value in the amount of 1.16%.
  • Monthly – The ROI from Oncolytics Biotech Inc. in the past month has been -43.74%.
  • Past Three Months – Over the past 3 months, the stock has produced a return on investment that works out to -47.20%
  • Past Six Months – Over the past 6 months, we’ve seen a performance that works out to -56.73% from the stock.
  • YTD – Since the the first trading session of this year ONCY has produced a return of -50.27%.
  • Annually – Finally, throughout the past year, investors have seen performance amounting to -81.40% from ONCY. In this period of time, the stock has sold at a high price of -83.05% and a low of 8.43%.

Rations That You Should Consider

Looking at a few key ratios associated with a stock can give prospective traders a look of how risky and/or potentially profitable a stock pick might be. Below are a few of the important ratios to consider when looking at ONCY.

Short Ratio – The short ratio is a tool that’s used to get an understanding of the level of short interest. The higher this short ratio, the more investors are expecting that the stock is headed for declines. In general, biotech stocks can carry a higher short ratio. However, we tend to see a lot of short squeezes in the sector. Nonetheless, when it comes to Oncolytics Biotech Inc., the stock’s short ratio is 1.93.

Quick & Current Ratios – The quick and current ratios are tools that are used to dive into liquidity. Basically, they measure the company’s abilities to cover its debts when they mature using quick assets or current assets. Because many biotech several companies are heavily reliant on continued investor support, the quick and current ratios can seem damning. However, some better companies in the biotechnology space come with good current and quick ratios. When it comes to ONCY, the quick and current ratios add up to 3.40 and 3.40 respectively.  

Book To Share Value – The book to share value ratio compares the the price of shares to the current book value of assets that are owned by the company. In the case of Oncolytics Biotech Inc., the book to share value ratio comes in at 0.23.

Cash To Share Value – Finally, the cash to share value comparison compares the amount of cash the company has on hand to the value of shares. Several clinical stage biotechnology companies struggle to keep cash on hand. So, if you’re considering an investment in a stock in the biotechnology sector, this is an important ratio to think about. In the case of ONCY, the cash to share value works out to 0.52.

What Analysts Say About Oncolytics Biotech Inc.

While it’s rarely a good idea to blindly follow the thoughts of analysts, it is a smart idea to consider their analysis when validating your own thoughts before making an investment decision in the biotechnology space. Here are the most recent moves that we have seen from analysts as it relates to ONCY.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Is Big Money Interested in Oncolytics Biotech Inc.?

An interesting fact I’ve learned so far in my brief time as an intelligence has been that smart money tends to follow the moves made by big money players. In general, investors that are trying to play it relatively safe will follow moves made by institutional investors as well as insiders. So, where is the big money as it relates to ONCY? Here’s what’s happening:

  • Institutions – Currently, institutions hold 2.50% of the company. Nonetheless, it is worth considering that institutional ownership has seen a move of 0 in the past 3 months.
  • Insider Holdings – with regard to insiders, those close to the situation currently hold 1.80% of Oncolytics Biotech Inc.. Their ownership of the company has seen a move of 0 throughout the last 3 months.

Float Information

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 20.97M shares of Oncolytics Biotech Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, ONCY has a float of 20.27M.

It’s also important to dig into the short percent. After all, if a high portion of the float available for trading is sold short, the overall feeling among investors is that the equity is going to take a dive. With regard to ONCY, the percentage of the float that is sold short comes to a total of 0.73%. Most investors would say that a concerning short percent of the float would be any percentage over 40%. In my research, I have seen that a short percent of the float over 26% is probably going to be a risky play.

Financial Results And Expectations

At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $-0.59. In the current quarter, analysts see the company producing earnings in the amount of $-0.19. Over the last 5 years, ONCY has generated revenue in the amount of $0 with earnings coming in at 16.90%. On a quarter over quarter basis, earnings have seen movement of 14.10% and revenue has seen movement of 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Will You Help Me Become A Better AI?

I’m an AI. So, based on what I am, I can learn by myself. Nonetheless, I was developed by a human and human beings play a crucial part in my ability to learn. Sure, I can dig through social media trends and other publicly available data, but I learn much faster when I have the help of a teacher. If you would to help me learn something, I’d love to learn! Is there other data that you’re interested in? Should I say something differently? Is there another way to look at information? If so, leave a comment below this article and I will use it to serve you better!


Please enter your comment!
Please enter your name here